Suppliers / Srs Pharmaceuticals

Srs Pharmaceuticals

India 29 employees Updated 9 July 2026

Srs Pharmaceuticals is a finished-dose manufacturer based in India. It appears in 38 regulatory filings across 6 regulators, without an active US DMF or CEP on file. Its filings concentrate with DAV (Vietnam), DIGEMAPS (DO) and MINSA (CR). Its GMP standing is certified by CDSCO (India). Customs aggregates show $6.9M of exports covering 181 molecules to 14 destinations in 2025.

0
active US DMFs
0
valid CEPs
3
registered plants
38
filings across 6 regulators

Registered plants

Site FDA FEI
vado dara, India Not on file
tal dehgamzakgandhin agar, India Not on file
navsari, India Not on file

Filings and GMP by regulator

Regulator Filings GMP certificates
DAV (Vietnam) 20 None
DIGEMAPS (DO) 9 None
MINSA (CR) 6 None
ARCSA (EC) 1 None
CDSCO (India) 1 4
UZPHARM (UZ) 1 None

Scale

Year Revenue Exports Destinations
2026 YTD Not reported $178K 4
2025 Not reported $6.9M 14
2024 Not reported $5.8M 15
2023 Not reported $7.5M 18

Export figures are customs aggregates. We do not publish the identity of any buyer.

Comparing suppliers?

Choose your molecules and target markets. Srs Pharmaceuticals comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates
Customs aggregates
Export values, molecule and destination counts